Norpace Cr
NDC Package 0025-2732-31
Package Information
Norpace Cr is norpace and Norpace CR are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 0025-2732 and is authorized under FDA application NDA018655.
Identification & Billing
- RxCUI: 209066 - Norpace 100 MG Oral Capsule
- RxCUI: 209066 - disopyramide 100 MG Oral Capsule [Norpace]
- RxCUI: 209066 - Norpace (as disopyramide phosphate) 100 MG Oral Capsule
- RxCUI: 209692 - Norpace 150 MG Oral Capsule
- RxCUI: 209692 - disopyramide 150 MG Oral Capsule [Norpace]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0025 - Pfizer Laboratories Div Pfizer Inc
- 0025-2732 - Norpace Cr
- 0025-2732-31 - 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 0025-2732 - Norpace Cr
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0025-2732-31 identifies a specific commercial package of 100 capsule, extended release in 1 bottle of Norpace Cr, labeled by Pfizer Laboratories Div Pfizer Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on July 20, 1982. The current certification is valid through October 31, 2025.
How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00025273231. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.